Comparison of two regimens of oral clindamycin versus dicloxacillin in the treatment of mild-to-moderate skin and soft-tissue infections

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 6, 1998, Pages 341-353

  Blaszczyk Kostanecka, Maria ^a   Dobozy, Attila ^b   Dominguez Soto, Luciano ^c   Guerrero, Robinson ^d   Hunyadi, Janos ^e   Lopera, Julio ^f   Maguiña, Ciro ^g   Peña, Adrian C ^h   Prieto, Mercedes ⁱ   Fabra Coronel, Remedios ^j   Saul, Amado ^k   Sivayathorn, Apichati ^l   Velmonte, Melecia ^m   Vosmik, Frantisek ⁿ   Zambrano, David ^o  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF SZEGED   (Hungary)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^d Dermatologic Clinic   (Chile)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f Hospital Regional Honorio Delgado Espinoza   (Peru)

^g UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^h UNIVERSITY OF THE EAST   (Philippines)

ⁱ Hospital Vargas de Caracas   (Venezuela)

^j UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^k HOSPITAL GENERAL DE MÉXICO   (Mexico)

^l MAHIDOL UNIVERSITY   (Thailand)

^m PHILIPPINE GENERAL HOSPITAL   (Philippines)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o Pharmacia and Upjohn   (Hong Kong)

more..

Author keywords

Clindamycin; Dicloxacillin; Skin infections; Soft tissue infections

Indexed keywords

CLINDAMYCIN; DICLOXACILLIN; PLACEBO;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CACHEXIA; CARBUNCLE; CELLULITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLICULITIS; FURUNCULOSIS; HUMAN; IMPETIGO; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT OUTCOME;

EID: 7144227300     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85036-4     Document Type: Article

References (35)

1. Feingold DS, Hirschmann JV. Approach to the patient with skin or soft tissue infection. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia: WB Saunders Corp; 1992:1064-1066.
2. Swartz MN. Cellulitis and subcutaneous tissue infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingston; 1996:909-929.
3. Roth RR, James WD. Microbiology of the skin: Resident flora, ecology, infection. J Am Acad Dermatol. 1989;20:367-390.
4. Ferrieri P, Dajani AS, Wannamaker LW, et al. Skin microflora. J Invest Dermatol. 1987; 88:65-70.
5. Hirschmann JV, Feingold DS. Staphylococcal and streptococcal skin or soft tissue infections. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia: WB Saunders Corp; 1992:1069-1071.
6. Hook EW III, Horton TM, Horton CA, et al. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295-301.
7. Chambers H, Neu HC, Penicillins. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingston; 1996:233-246.
8. Gorbach SL, Zurenko GE. Clindamycin: Antimicrobial activity. In: Zambrano D, ed. Clindamycin in the Treatment of Human Infections. Kalamazoo, MI: Pharmacia and Upjohn Company; 1997:1-1-1-40.
9. Rodriguez-Noriega E. Clindamycin in the treatment of skin and soft tissue and bone and joint infections. In: Zambrano D, ed. Clindamycin in the Treatment of Human Infections. 2nd ed. Kalamazoo, MI: Pharmacia and Upjohn Company; 1997:10-1-10-35.
10. Bagley DH, MacLowry J, Beazley RM, et al. Antibiotic concentrations in human tissues. 14th ICCAC, 1974.
11. Berger SA, Barza M, Haher J, et al. Penetration of clindamycin into decubitus ulcers. Antimicrob Agents Chemother. 1978;14:498-499.
12. Mouzas GL, Mummery G, Syed A. The value of clindamycin phosphate in the treatment of patients with superficial abscesses. Br J Clin Pract. 1980;34:242-245.
13. Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis. 1981; 144:472-479.
14. Hand WL, King-Thompson NL, Steinberg TH. Interactions of antibiotics and phagocytes. J Antimicrob Chemother. 1993;12(Suppl C):1-11.
15. Johnson J, Hand WL, Francis JB, et al. Antibiotic uptake by alveolar macrophages. J Lab Clin Med. 1980;95:429-439.
16. Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest. 1981;22:1249-1256.
17. Phillips TJ, Dover JS. Recent advances in dermatology. NEJM. 1992;326:167-178.
18. Barton LL, Freedman AD, Purilla MG. Impetigo contagiosa. A comparison of erythromycin and dicloxacillin therapy. Pediatr Dermatol. 1988;5:88-91.
19. Pusponegoro EHD, Wiryadi BC. Clindamycin and cloxacillin compared in the treatment of skin and soft tissue infections. Clin Ther. 1990;12:236-241.
20. SAS Institute, Inc. SAS User's Guide: Statistics, Version 6. 1st ed. Cary, NC: SAS Institute, Inc; 1989.
21. Finnerty EF, Folan DW Jr. Changing antibiotic sensitivities of bacterial skin disease: Office practice 1977-1978. Cutis. 1979;23:227-230.
22. Carruthers R, Cox GB. Impetigo and its treatment. Med J Aust. 1987;147:56-57.
23. Disanto AR. Serum clindamycin levels study following multiple oral doses of Cleocin HCl given according to a Q.6H. and a Q.12H. Dosage regimen. Protocol No. 313, Clinical Study #036. Kalamazoo, MI: The Pharmacia and Upjohn Company, 1972.
24. Jungbluth GL, Easterday PL, Borin MT, et al. Bioavailability evaluation of clindamycin following two multiple dose regimens of Cleocin HCl capsules. Technical Report 7215/89/012. Kalamazoo, MI: The Pharmacia and Upjohn Company, September 8, 1989.
25. Bundtzen RW, Gerber AU, Cohn DL, et al. Postantibiotic suppression of bacterial growth. Rev Infect Dis. 1981;3:28-37.
26. Kuenzi B, Segessenmann Ch, Gerber AU. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected Gram-positive bacteria and Haemophillus influenzae. J Antimicrob Chemother. 1987;20(Suppl B):39-46.
27. Vogelman B, Gudmundsson S, Turnidge J, et al. In vivo postantibiotic effect in thigh infection in neutropenic mice. J Infect Dis. 1988;157:287-298.
28. Wilson DH. Clindamycin in the treatment of soft tissue infections: A review of 15019 patients. Br J Surg. 1980;67:93-96.
29. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with lowdose oral clindamycin therapy. JAMA. 1988;260:2682-2685.
30. Gallegos B, Rios A, Espidel A, et al. A double-blind multicenter comparative study of two regimens of clindamycin hydrochloride in the treatment of patients with acute streptococcal tonsillitis/pharyngitis. Clin Ther. 1995;17:613-621.
31. Swartzberg JE, Maresca RM, Remington JS. Gastrointestinal side effects associated with clindamycin. Arch Intern Med. 1976;136:876-879.
32. Leigh DA, Simmons K, Williams S. Gastro-intestinal side effects following clindamycin, and lincomycin treatment - a follow up study. J Antimicrob Chemother. 1980;6:639-645.
33. Lusk RH, Fekety FR Jr, Silva J Jr, et al. Gastrointestinal side of clindamycin and ampicillin therapy. J Infect Dis. 1977;135(Suppl):S111-S119.
34. Brause BD, Romankiewics JA, Gotz V, et al. Comparative study of diarrhea associated with clindamycin and ampicillin therapy. Am J Gastroenterol. 1980;73:244-248.
35. Baliña LM, Gatti JC, Cardama JE, et al. Estudio clínico-bacteriologico de la lincomicina por vía oral. Orientación Médica. 1966;7:247-248.